Blog Julio G. Martinez-Clark 4/25/25 Julio G. Martinez-Clark 4/25/25 How Clinical Trial Services Are Shaping the Future of Drug Development Read More Julio G. Martinez-Clark 4/23/25 Julio G. Martinez-Clark 4/23/25 How Argentina Is Supporting First-in-Human Medical Device Trials Read More Julio G. Martinez-Clark 4/21/25 Julio G. Martinez-Clark 4/21/25 The FDA Workforce Reduction: A Catalyst for Medtech's Shift Toward Latin American Clinical Trials Read More Julio G. Martinez-Clark 4/21/25 Julio G. Martinez-Clark 4/21/25 The Role of CROs in Navigating Latin America’s Regulatory Landscape Read More Julio G. Martinez-Clark 4/18/25 Julio G. Martinez-Clark 4/18/25 The Role of CROs in Accelerating Clinical Trials in Brazil Read More Julio G. Martinez-Clark 4/18/25 Julio G. Martinez-Clark 4/18/25 How Peru Is Supporting the Growth of Clinical Research in Latin America Read More Julio G. Martinez-Clark 4/15/25 Julio G. Martinez-Clark 4/15/25 Why Chile Is a Strategic Location for Medical Device Clinical Trials Read More Julio G. Martinez-Clark 4/11/25 Julio G. Martinez-Clark 4/11/25 The Role of Technology in Modern Medical Device Development Read More Julio G. Martinez-Clark 4/10/25 Julio G. Martinez-Clark 4/10/25 The Future of Clinical Trials in Latin America’s Emerging Markets Read More Julio G. Martinez-Clark 4/9/25 Julio G. Martinez-Clark 4/9/25 Plain Language Protocols: Accelerate Ethics Approvals & ROI in Latin America with bioaccess®’s Ready-to-Use Documents Read More Julio G. Martinez-Clark 4/8/25 Julio G. Martinez-Clark 4/8/25 The Impact of Medical Devices on Healthcare Innovation in Latin America Read More Julio G. Martinez-Clark 4/6/25 Julio G. Martinez-Clark 4/6/25 The Advantages of Conducting Clinical Trials in Ecuador Read More Julio G. Martinez-Clark 4/2/25 Julio G. Martinez-Clark 4/2/25 How Colombia Is Becoming a Hub for Early Feasibility Medical Device Trials Read More Julio G. Martinez-Clark 3/31/25 Julio G. Martinez-Clark 3/31/25 Why Latin America Is a Hotspot for Early Feasibility Medical Device Trials Read More Julio G. Martinez-Clark 3/28/25 Julio G. Martinez-Clark 3/28/25 Why Patient Diversity in Latin America Is a Game-Changer for Clinical Trials Read More Julio G. Martinez-Clark 3/27/25 Julio G. Martinez-Clark 3/27/25 The Role of Regulatory Frameworks in Latin America’s Clinical Trials Industry Read More Julio G. Martinez-Clark 3/24/25 Julio G. Martinez-Clark 3/24/25 The Emerging Clinical Trials Market in Paraguay Read More Julio G. Martinez-Clark 3/21/25 Julio G. Martinez-Clark 3/21/25 Why Argentina Is a Top Destination for Clinical Trials in Latin America Read More Julio G. Martinez-Clark 3/21/25 Julio G. Martinez-Clark 3/21/25 How Medical Device CROs Ensure Compliance Without Compromising Innovation Read More Julio G. Martinez-Clark 3/20/25 Julio G. Martinez-Clark 3/20/25 Enhancing Trial Integrity: The Critical Role of Oversight Committees for US Medical Device Sponsors Conducting Early Feasibility Studies in Latin America Read More Older Posts
Julio G. Martinez-Clark 4/25/25 Julio G. Martinez-Clark 4/25/25 How Clinical Trial Services Are Shaping the Future of Drug Development Read More
Julio G. Martinez-Clark 4/23/25 Julio G. Martinez-Clark 4/23/25 How Argentina Is Supporting First-in-Human Medical Device Trials Read More
Julio G. Martinez-Clark 4/21/25 Julio G. Martinez-Clark 4/21/25 The FDA Workforce Reduction: A Catalyst for Medtech's Shift Toward Latin American Clinical Trials Read More
Julio G. Martinez-Clark 4/21/25 Julio G. Martinez-Clark 4/21/25 The Role of CROs in Navigating Latin America’s Regulatory Landscape Read More
Julio G. Martinez-Clark 4/18/25 Julio G. Martinez-Clark 4/18/25 The Role of CROs in Accelerating Clinical Trials in Brazil Read More
Julio G. Martinez-Clark 4/18/25 Julio G. Martinez-Clark 4/18/25 How Peru Is Supporting the Growth of Clinical Research in Latin America Read More
Julio G. Martinez-Clark 4/15/25 Julio G. Martinez-Clark 4/15/25 Why Chile Is a Strategic Location for Medical Device Clinical Trials Read More
Julio G. Martinez-Clark 4/11/25 Julio G. Martinez-Clark 4/11/25 The Role of Technology in Modern Medical Device Development Read More
Julio G. Martinez-Clark 4/10/25 Julio G. Martinez-Clark 4/10/25 The Future of Clinical Trials in Latin America’s Emerging Markets Read More
Julio G. Martinez-Clark 4/9/25 Julio G. Martinez-Clark 4/9/25 Plain Language Protocols: Accelerate Ethics Approvals & ROI in Latin America with bioaccess®’s Ready-to-Use Documents Read More
Julio G. Martinez-Clark 4/8/25 Julio G. Martinez-Clark 4/8/25 The Impact of Medical Devices on Healthcare Innovation in Latin America Read More
Julio G. Martinez-Clark 4/6/25 Julio G. Martinez-Clark 4/6/25 The Advantages of Conducting Clinical Trials in Ecuador Read More
Julio G. Martinez-Clark 4/2/25 Julio G. Martinez-Clark 4/2/25 How Colombia Is Becoming a Hub for Early Feasibility Medical Device Trials Read More
Julio G. Martinez-Clark 3/31/25 Julio G. Martinez-Clark 3/31/25 Why Latin America Is a Hotspot for Early Feasibility Medical Device Trials Read More
Julio G. Martinez-Clark 3/28/25 Julio G. Martinez-Clark 3/28/25 Why Patient Diversity in Latin America Is a Game-Changer for Clinical Trials Read More
Julio G. Martinez-Clark 3/27/25 Julio G. Martinez-Clark 3/27/25 The Role of Regulatory Frameworks in Latin America’s Clinical Trials Industry Read More
Julio G. Martinez-Clark 3/24/25 Julio G. Martinez-Clark 3/24/25 The Emerging Clinical Trials Market in Paraguay Read More
Julio G. Martinez-Clark 3/21/25 Julio G. Martinez-Clark 3/21/25 Why Argentina Is a Top Destination for Clinical Trials in Latin America Read More
Julio G. Martinez-Clark 3/21/25 Julio G. Martinez-Clark 3/21/25 How Medical Device CROs Ensure Compliance Without Compromising Innovation Read More
Julio G. Martinez-Clark 3/20/25 Julio G. Martinez-Clark 3/20/25 Enhancing Trial Integrity: The Critical Role of Oversight Committees for US Medical Device Sponsors Conducting Early Feasibility Studies in Latin America Read More
